Conagra Brands Launches 'GLP-1 Friendly' Product Labels to Counter Appetite Decline
Conagra Brands, Inc. (NYSE:CAG) is responding to a decline in consumer appetite driven by the growing use of GLP-1 weight-loss drugs like Ozempic and Wegovy. The company has introduced 'GLP-1 friendly' labels on over two dozen high-protein, high-fiber Healthy Choice frozen meals, which are already outselling similar products from competitors. This strategy is part of a broader effort to adapt as households using GLP-1 medications reduce grocery spending by 5.5% and calorie consumption by 21%, according to industry research. Conagra's financial performance has been under pressure recently, with its fiscal fourth-quarter results showing a $1.62 billion net loss largely due to a non-cash goodwill impairment charge of $1.96 billion. The company also cut its dividend in half and expects organic sales declines for 2027 as it faces margin compression from higher costs like tariffs. To support the turnaround, Conagra is investing more in brand-building and supply chain modernization while shifting capital away from less strategic areas.
Tickers: $CAG
Topics: consumer behavior GLP-1 drugs packaged food industry product labeling